You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in API rasagiline


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing rasagiline

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Teva Pharmaceuticals USA Inc RASAGILINE rasagiline 0093-3060 MANNITOL
Teva Pharmaceuticals USA Inc RASAGILINE rasagiline 0093-3060 SILICON DIOXIDE
Teva Pharmaceuticals USA Inc RASAGILINE rasagiline 0093-3060 STARCH, CORN
Teva Pharmaceuticals USA Inc RASAGILINE rasagiline 0093-3060 STEARIC ACID
Teva Pharmaceuticals USA Inc RASAGILINE rasagiline 0093-3060 TALC
Teva Pharmaceuticals USA Inc RASAGILINE rasagiline 0093-3061 MANNITOL
Teva Pharmaceuticals USA Inc RASAGILINE rasagiline 0093-3061 SILICON DIOXIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing rasagiline

Company Ingredient NDC Excipient
Torrent Pharmaceuticals Limited rasagiline 13668-447 MANNITOL
Torrent Pharmaceuticals Limited rasagiline 13668-447 SILICON DIOXIDE
Torrent Pharmaceuticals Limited rasagiline 13668-447 STARCH, CORN
Torrent Pharmaceuticals Limited rasagiline 13668-447 STEARIC ACID
Torrent Pharmaceuticals Limited rasagiline 13668-447 TALC
NorthStar RxLLC rasagiline 16714-770 CELLULOSE, MICROCRYSTALLINE
NorthStar RxLLC rasagiline 16714-770 CITRIC ACID MONOHYDRATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for rasagiline

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: CELLULOSE, MICROCRYSTALLINE

rasagiline drug variants containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
NorthStar RxLLC rasagiline 16714-770
Macleods Pharmaceuticals Limited rasagiline 33342-308
Micro Labs Limited rasagiline 42571-220
Ascend Laboratories LLC rasagiline 67877-259
Bryant Ranch Prepack rasagiline 72162-2383
Avet Pharmaceuticals Inc rasagiline mesylate 23155-746
Carnegie Pharmaceuticals LLC rasagiline mesylate 80005-141
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: CITRIC ACID MONOHYDRATE

rasagiline drug variants not containing CITRIC ACID MONOHYDRATE

Company Ingredient NDC
Teva Pharmaceuticals USA Inc rasagiline 0093-3060
Teva Pharmaceuticals USA Inc rasagiline 0093-3061
Torrent Pharmaceuticals Limited rasagiline 13668-447
Macleods Pharmaceuticals Limited rasagiline 33342-308
AvKARE rasagiline 42291-779
Chartwell RX LLC rasagiline 62135-676
Aphena Pharma Solutions - Tennessee LLC rasagiline mesylate 43353-015
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: SILICON DIOXIDE

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: TALC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links